SF Pulse | June 2025

Issue 6 of SF Pulse is out now! The issue highlights the following: FtFA Academic Chair Oksana Pyzik issues a powerful call alongside the 78th World Health Assembly to hold those responsible for producing and distributing falsified medicines accountable. Writing for ENACT, researcher Aimé Raoul Sumo Tayo argues that despite recent progress, Read more…

Johns Hopkins releases report on 2024 Symposium on Public Health Strategies to Combat Substandard and Falsified Drugs

Held at the Johns Hopkins Bloomberg Center in Washington, DC, the 2024 symposium welcomed ~ 103 attendees who shared insights and assessed progress. It charted a collective course of action to combat the threat posed by substandard and falsified drugs. Through enlightening keynote addresses and interactive discussions, the event emphasized Read more…

SF Pulse | March 2025

Issue 5 of SF Pulse is out now! The issue highlights the following: A call to World Health Organization to expand its existing Prequalification of Medicines Programme, which helps ensure enforcement of quality standards for a wide range of medical products. How counterfeiters are now successfully replicating packaging QR codes Read more…

Addressing substandard and falsified medical products at the156th session of WHO’s Executive Board

This statement was delivered by the World Heart Federation on behalf of Fight the Fakes Alliance at the 156th session of the WHO Executive Board: Honourable Chair, Distinguished Delegates, The World Heart Federation, supported by the Fight the Fakes Alliance, welcomes the independent evaluation of the Member State Mechanism on Read more…